Skip to main content
Noma survivors: closer to getting the attention they deserve

Neglected diseases

Neglected diseases disproportionally affect people in the world’s least-developed countries and there are few tools available with which to diagnose and treat.

They cover neglected tropical diseases, such as kala azar (visceral leishmaniasis) and sleeping sickness (human African trypanosomiasis), plus issues such as snakebite envenoming, but also Chagas, noma, cutaneous leishmaniasis, and others.

These diseases are considered ‘neglected’, as – although they are usually life-threatening and claim thousands of lives every year – the pharmaceutical and diagnostic industries ignore the development of vaccines, diagnostic tools and drugs to tackle them.

Neglected diseases

 
Meningitis

Multiple outbreaks as meningitis season starts in Africa

Project Update 31 Mar 2004
 
Nepal

Rukum: A hospital on the top of the world

In the Media 4 Mar 2004
 
Sudan

Heavy rains in northern Sudan leave kala azar project virtually isolated

Project Update 19 Sep 2003
 
Website

Drugs for Neglected Diseases initiative (DNDi)

Drugs for Neglected Diseases initiative (DNDi) is a collaborative, patients’ needs-driven, non-profit drug research and development (R&D) organization that is developing new treatments for neglected diseases.
dndi.org
 
DNDi

Neglected diseases kill poor

Project Update 4 Jul 2003
 
DNDi

New Body Set to Fight Killer Diseases West Ignores

Project Update 3 Jul 2003
Advanced HIV management in Homa Bay
Medical Resource

MSF Field Research

We produce important research based on our field experience. So far, we have published articles in over 100 peer-reviewed journals. These articles have often changed clinical practice and have been used for humanitarian advocacy. All of these articles can be found on our dedicated Field Research website.

Visit site